Search Results 101-110 of 17276 for hba1c

  1. A Study of the Effect of Colesevelam on Glucose Metabolism in Patients with Type 2 Diabetes - Mayo Clinic

    HbA1c greater than 9.0%; Have not been stable on all medications for a period exceeding 3 months; Use of drugs or agents within the past 2 weeks or planned ...

  2. A Study Of The Clinical Experience And Acceptance Of The Artificial Pancreas

    HbA1c level <10.5% at screening; For females, not currently known to be pregnant. If female and sexually active, must agree to use a form of contraception to ...

  3. A Study Of The Metabolome And Microbiome Following Bariatric Surgery, And The Effect On Metabolism In Patients With Type 2 Diabetes - Mayo Clinic

    ... (HbA1c and number of oral medications needed to achieve glycemic control) of diabetes. Exclusion Criteria. Subjects < 20 years of age will not be studied to ...

  4. Emricasan, A Caspase Inhibitor, For Treatment Of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    Uncontrolled diabetes mellitus (HbA1c >9%); Diabetes medications should be stable within 3 months of screening except for medications titrated to blood ...

  5. Safety And Efficacy Of Selonsertib In Adults With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5% (or serum fructosamine ≤ 381 μmol if HbA1c is unable to be resulted). Exclusion Criteria: Prior history of decompensated liver disease ...

  6. Safety And Efficacy Of Selonsertib In Adults With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5% (or serum fructosamine ≤ 381 μmol if HbA1c is unable to be resulted). Exclusion Criteria: Prior history of decompensated liver disease ...

  7. Blood Tests (Phlebotomy)​ - Mayo Clinic Healthcare

    ​Common tests may include: Full blood count (FBC): Evaluates the number of blood cells in your blood to test for blood-related diseases; Blood glucose and HbA1c ...

  8. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    Glycated hemoglobin (HbA1c) <7.0% or >9.0% via central lab test at visit 1; Experienced none or only 1 episode of documented symptomatic and/or severe ...

  9. A Study of PDD in Type 2 Diabetes - Mayo Clinic

    HbA1C > 9 % at enrollment. Prior diagnosis, or signs and symptoms, of heart failure. Currently taking a loop diuretic. Myocardial infarction within 6 months ...

  10. Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes - Mayo Clinic

    HbA1c ≥ 6.5%; Use of glucose-lowering agents. For female subjects: positive pregnancy test at the time of enrollment or study; History of prior upper ...